Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer

Anticancer vaccines represent a promising approach for effective treatment of cancer and along with recent advantages of nucleic acid-based vaccines for other diseases form a prospective and potentially efficacious direction of the research, development and clinical applications. Despite the ongoing...

Descripción completa

Detalles Bibliográficos
Autores principales: Gildiz, Simav, Minko, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663189/
https://www.ncbi.nlm.nih.gov/pubmed/36376606
http://dx.doi.org/10.1007/s11095-022-03434-4
_version_ 1784830817773551616
author Gildiz, Simav
Minko, Tamara
author_facet Gildiz, Simav
Minko, Tamara
author_sort Gildiz, Simav
collection PubMed
description Anticancer vaccines represent a promising approach for effective treatment of cancer and along with recent advantages of nucleic acid-based vaccines for other diseases form a prospective and potentially efficacious direction of the research, development and clinical applications. Despite the ongoing several clinical trials of mRNA vaccines for the treatment of various types of cancer, to-date no cancer vaccines were approved by the US Food and Drug Administration. The present review analyzes and summarizes major approaches for treating of different forms of ovarian cancer including mRNA-based vaccines as well as nanotechnology-based approaches for their delivery. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9663189
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-96631892022-11-14 Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer Gildiz, Simav Minko, Tamara Pharm Res Review Article Anticancer vaccines represent a promising approach for effective treatment of cancer and along with recent advantages of nucleic acid-based vaccines for other diseases form a prospective and potentially efficacious direction of the research, development and clinical applications. Despite the ongoing several clinical trials of mRNA vaccines for the treatment of various types of cancer, to-date no cancer vaccines were approved by the US Food and Drug Administration. The present review analyzes and summarizes major approaches for treating of different forms of ovarian cancer including mRNA-based vaccines as well as nanotechnology-based approaches for their delivery. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2022-11-14 2023 /pmc/articles/PMC9663189/ /pubmed/36376606 http://dx.doi.org/10.1007/s11095-022-03434-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Gildiz, Simav
Minko, Tamara
Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
title Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
title_full Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
title_fullStr Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
title_full_unstemmed Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
title_short Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
title_sort nanotechnology-based nucleic acid vaccines for treatment of ovarian cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663189/
https://www.ncbi.nlm.nih.gov/pubmed/36376606
http://dx.doi.org/10.1007/s11095-022-03434-4
work_keys_str_mv AT gildizsimav nanotechnologybasednucleicacidvaccinesfortreatmentofovariancancer
AT minkotamara nanotechnologybasednucleicacidvaccinesfortreatmentofovariancancer

Ejemplares similares